Navigation Links
Biotech flourishes in 2005 while Big Pharma is on the decline

Goodbye, 2005, and hello, 2006! I sit hear writing this article as I listen, appropriately, to a new Cream anthology album called "Cream Gold" (released in 2005 - not to be confused with the live Cream concerts held in 2005). Why Cream, you may ask? Well, the successful re-emergence of this supergroup in 2005 via a series of concerts held in London and NewYork's Madi......

Full article >>> s but also in other industries such as the software/hardware and internet industries. For example, internet company Google went public in 2004, and whose value skyrocketed to a market cap of $123 billion at the end of 2005 with a stock price of $414.86 (versus its IPO debut in August, 2004 with a stock price of $85/share). Google's annual revenue is about $5.3 billion/year and income of $1.4 billi......

Full article >>> 1">$23.32$27.31<15%>$172 billion3. Glaxo Smithkline (GSK)$50.48<......

Full article >>> width="19.94%" rowspan="1" colspan="1"><1%>$69 billion8. Eli Lilly (LLY)$56.59$56.771. Genentech (DNA)$92.50$54.25+71%$98 billion
Full article >>> on & Johnson surpassing Pfizer for the first time in market valuation, a similar phenomenon took place in the land of biotech with Genentech surpassing Amgen in market valuation by a hair (give or take a billion). Note that both Genentech and Amgen have market caps superior to all but the top 5 Big Pharma companies.

All of the top five Big Biotech companies had very solid double-digit sto......

Full article >>> those of the author and do not necessarily reflect the views of The Wisconsin Technology Network, LLC. (WTN). WTN, LLC, accepts no legal liability or responsibility for any claims made or opinions expressed herein.......

Full article >>>
'"/>

Source:wistechnology.com By Michael Rosen 01/04/06


Related biology technology :

1. Biotech officials praise focus of new venture fund
2. Biotech executive books a career flight thats closer to home
3. Gala Biotech among companies sold for $3.3 billion
4. Biotech with Madison ties raises $21M in capital
5. Biotech firm uses live heart tissue in drug screens
6. Biotech talent drew venture-funded firm to Madison
7. Biotech firm has strokes, Alzheimers in its sights
8. 42 days until the 2006 Olympics of Biotechnology in Chicago
9. Biotech crops gaining acceptance, but their full promise has yet to be fulfilled
10. Biotech leads list of top U.S. companies to work for
11. Though Weakening, Biotech IPO Market Still Viable, Burril & Co. Says
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/10/2016)... ... February 10, 2016 , ... PatientCrossroads announces that ... secure online PatientCrossroads platform, has exceeded both its one-year and overall recruitment goals ... study, which seeks to advance understanding of the hereditary risks for certain kinds ...
(Date:2/10/2016)... ... February 10, 2016 , ... Cenna Bioscience Inc., an emerging biopharmaceutical company focused ... announced today it has been selected to present at the Cavendish Global Health Impact ... Florida. The purpose of the Forum is to help family offices and foundations ...
(Date:2/9/2016)... , Feb. 9, 2016  Regenicin, Inc. (OTC ... specializing in the development and commercialization of regenerative ... tissues and organs, recently reported the Company,s operating ... quarter of 2016. Lonza America , ... 2015 fiscal year in the process of consummating ...
(Date:2/9/2016)... ... 2016 , ... Clinovo , the cloud-based eClinical software ... Capture (EDC) system ClinCaptureand its new Contract Research Organization (CRO) Partner Program ... San Mateo, California on February 10th and 11th. Watch 2-min video . ...
Breaking Biology Technology:
(Date:2/9/2016)... (NASDAQ: AWRE ), a leading supplier of biometrics software and ... ended December 31, 2015.  --> ... million, an increase of 61% compared to $4.3 million in the ... 2015 was $2.6 million compared to $0.2 million in the fourth ... Higher revenue and operating income in the fourth quarter of ...
(Date:2/3/2016)... -- --> --> Fourth quarter 2015: ... 1,187% compared with fourth quarter of 2014. Gross margin was ... 30.0). Earnings per share increased to SEK 6.39 (loss: 0.49). ... 74.7). , --> --> ... M (233.6), up 1,142% compared with 2014. Gross margin was ...
(Date:2/2/2016)... 2016 This BCC Research report provides ... reviewing the recent advances in high throughput ‘omic ... field forward. Includes forecast through 2019. ... and opportunities that exist in the bioinformatic market. ... as well as IT and bioinformatics service providers. ...
Breaking Biology News(10 mins):